Hyperlipidemia promotes thrombosis after injury to atherosclerotic vessels in apolipoprotein E-deficient mice

被引:74
作者
Eitzman, DT
Westrick, RJ
Xu, ZJ
Tyson, J
Ginsburg, D
机构
[1] Univ Michigan, Med Ctr, Cardiovasc Res Ctr, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Med Ctr, Dept Internal Med, Div Mol Med & Human Genet, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Med Ctr, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA
关键词
carotid artery; transgenic mice; cholesterol; plaque; rose bengal;
D O I
10.1161/01.ATV.20.7.1831
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The increased risk of hyperlipidemia on the development of complications of atherosclerosis is well established. Cholesterol-lowering therapies lead to a decrease in the incidence of vascular thrombotic events that is out of proportion to the reduction in plaque size. This suggests that the occurrence of acute thrombosis overlying a disrupted plaque is influenced by changes in lipid levels, The influence of acute hyperlipidemia on the development of thrombosis overlying an atherosclerotic plaque in vivo has not been extensively studied. We used a murine model of vascular injury induced by a photochemical reaction to elicit thrombus formation overlying an atherosclerotic plaque. Fifteen apolipoprotein E-deficient mice were maintained on normal chow until the age of 30 weeks. Five days before the induction of thrombosis, 6 mice were stal ted on a high fat diet, and 9 mice were continued on normal chow. Mice then underwent photochemical injury to the common carotid artery immediately proximal to the carotid bifurcation, where an atherosclerotic plaque is consistently present. Mice maintained on normal chow developed occlusive thrombi, determined by cessation of blood flow, 44 +/- 5 minutes (mean +/- SEM) after photochemical injury, whereas mice fed a high fat chow developed occlusive thrombosis at 27 +/- 3 minutes (P < 0.02), Histological analysis confirmed the presence of acute thrombus formation overlying an atherosclerotic plaque. These studies demonstrate a useful model for assessing the determinants of thrombosis in the setting of atherosclerosis and show that acute elevations in plasma cholesterol facilitate thrombus formation at sites of atherosclerosis after vascular injury.
引用
收藏
页码:1831 / 1834
页数:4
相关论文
共 24 条
[1]   CORONARY ANGIOGRAPHIC CHANGES WITH LOVASTATIN THERAPY - THE MONITORED ATHEROSCLEROSIS REGRESSION STUDY (MARS) [J].
BLANKENHORN, DH ;
AZEN, SP ;
KRAMSCH, DM ;
MACK, WJ ;
CASHINHEMPHILL, L ;
HODIS, HN ;
DEBOER, LWV ;
MAHRER, PR ;
MASTELLER, MJ ;
VAILAS, LI ;
ALAUPOVIC, P ;
HIRSCH, LJ .
ANNALS OF INTERNAL MEDICINE, 1993, 119 (10) :969-976
[2]  
Castelli W P, 1992, Ann Epidemiol, V2, P23, DOI 10.1016/1047-2797(92)90033-M
[3]   INCREASED FIBRINOGEN BINDING TO PLATELETS FROM PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA [J].
DIMINNO, G ;
SILVER, MJ ;
CERBONE, AM ;
RAINONE, A ;
POSTIGLIONE, A ;
MANCINI, M .
ARTERIOSCLEROSIS, 1986, 6 (02) :203-211
[4]  
DRAKE TA, 1991, AM J PATHOL, V138, P601
[5]   Plasminogen activator inhibitor-1 and vitronectin promote vascular thrombosis in mice [J].
Eitzman, DT ;
Westrick, RJ ;
Nabel, EG ;
Ginsburg, D .
BLOOD, 2000, 95 (02) :577-580
[6]   Vitronectin inhibits the thrombotic response to arterial injury in mice [J].
Fay, WP ;
Parker, AC ;
Ansari, MN ;
Zheng, XX ;
Ginsburg, D .
BLOOD, 1999, 93 (06) :1825-1830
[7]   MECHANISMS LEADING TO MYOCARDIAL-INFARCTION - INSIGHTS FROM STUDIES OF VASCULAR BIOLOGY [J].
FUSTER, V .
CIRCULATION, 1994, 90 (04) :2126-2146
[8]   Tissue factor pathway inhibitor in complex with low density lipoprotein isolated from human plasma does not possess anticoagulant function in tissue factor-induced coagulation in vitro [J].
Hansen, JB ;
Huseby, KR ;
Huseby, NE ;
Ezban, M ;
Nordoy, A .
THROMBOSIS RESEARCH, 1997, 85 (05) :413-425
[9]   CORRELATION OF VITAMIN-K-DEPENDENT CLOTTING FACTORS WITH CHOLESTEROL AND TRIGLYCERIDES IN HEALTHY-YOUNG ADULTS [J].
HOFFMAN, CJ ;
LAWSON, WE ;
MILLER, RH ;
HULTIN, MB .
ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (11) :1737-1740
[10]   LIPOPROTEINS INHIBIT THE SECRETION OF TISSUE-PLASMINOGEN ACTIVATOR FROM HUMAN ENDOTHELIAL-CELLS [J].
LEVIN, EG ;
MILES, LA ;
FLESS, GM ;
SCANU, AM ;
BAYNHAM, P ;
CURTISS, LK ;
PLOW, EF .
ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (03) :438-442